{"id":"https://openalex.org/W1968440192","doi":"https://doi.org/10.1089/adt.2006.049","title":"Development of a Simple and Robust Assay to Screen for Inhibitors of Sphingosine Kinases","display_name":"Development of a Simple and Robust Assay to Screen for Inhibitors of Sphingosine Kinases","publication_year":2007,"publication_date":"2007-04-01","ids":{"openalex":"https://openalex.org/W1968440192","doi":"https://doi.org/10.1089/adt.2006.049","mag":"1968440192","pmid":"https://pubmed.ncbi.nlm.nih.gov/17477830"},"language":"en","primary_location":{"id":"doi:10.1089/adt.2006.049","doi":"https://doi.org/10.1089/adt.2006.049","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2006.049","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050723461","display_name":"Hiroko Togame","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroko Togame","raw_affiliation_strings":["Discovery Research Laboratories, Shionogi &amp; Co., Ltd., Osaka, Japan","Discovery Research Laboratories, Shionogi & Co., Ltd., Sagisu, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research Laboratories, Shionogi &amp; Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]},{"raw_affiliation_string":"Discovery Research Laboratories, Shionogi & Co., Ltd., Sagisu, Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072127202","display_name":"Reiko Dodo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Reiko Dodo","raw_affiliation_strings":["Discovery Research Laboratories, Shionogi &amp; Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research Laboratories, Shionogi &amp; Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090096022","display_name":"Tetsuya Inaoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuya Inaoka","raw_affiliation_strings":["Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110259976","display_name":"Peter Reinemer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Reinemer","raw_affiliation_strings":["Proteros Biostructures GmbH, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proteros Biostructures GmbH, Martinsried, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1088,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.41402041,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"5","issue":"2","first_page":"215","last_page":"224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sphingosine-kinase","display_name":"sphingosine kinase","score":0.9459999799728394},{"id":"https://openalex.org/keywords/sphingosine-1-phosphate","display_name":"sphingosine-1-phosphate","score":0.9810000061988831},{"id":"https://openalex.org/keywords/kinase-inhibitor-screening","display_name":"kinase inhibitor screening","score":0.7419999837875366},{"id":"https://openalex.org/keywords/automated-screening","display_name":"automated screening","score":0.45899999141693115},{"id":"https://openalex.org/keywords/n-n-dimethylsphingosine","display_name":"N,N-dimethylsphingosine","score":0.9020000100135803},{"id":"https://openalex.org/keywords/adp-inhibition","display_name":"ADP inhibition","score":0.871999979019165},{"id":"https://openalex.org/keywords/kinetic-parameters","display_name":"kinetic parameters","score":0.4169999957084656},{"id":"https://openalex.org/keywords/z-factor","display_name":"Z' factor","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2778703144","wikidata":"https://www.wikidata.org/wiki/Q46298","display_name":"Sphingosine","level":3,"score":0.9015586376190186},{"id":"https://openalex.org/C61705674","wikidata":"https://www.wikidata.org/wiki/Q410395","display_name":"Sphingolipid","level":2,"score":0.6884927749633789},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6574123501777649},{"id":"https://openalex.org/C2777700496","wikidata":"https://www.wikidata.org/wiki/Q7576797","display_name":"Sphingosine kinase","level":5,"score":0.6517579555511475},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6404950618743896},{"id":"https://openalex.org/C2776596873","wikidata":"https://www.wikidata.org/wiki/Q418267","display_name":"Sphingosine-1-phosphate","level":4,"score":0.6072433590888977},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5360693335533142},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5213003158569336},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5171558260917664},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4888159930706024},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11140507459640503}],"mesh":[{"descriptor_ui":"D000099157","descriptor_name":"Sphingosine Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001331","descriptor_name":"Automation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004591","descriptor_name":"Electrophoresis, Polyacrylamide Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008246","descriptor_name":"Lysophospholipids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013110","descriptor_name":"Sphingosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013110","descriptor_name":"Sphingosine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/adt.2006.049","doi":"https://doi.org/10.1089/adt.2006.049","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2006.049","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},{"id":"pmid:17477830","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17477830","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Assay and drug development technologies","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4043000042438507,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1516689988","https://openalex.org/W1546623153","https://openalex.org/W1553823938","https://openalex.org/W1966411711","https://openalex.org/W1977843296","https://openalex.org/W1980405866","https://openalex.org/W1985430829","https://openalex.org/W1987121211","https://openalex.org/W1991001144","https://openalex.org/W1993449698","https://openalex.org/W1996965660","https://openalex.org/W1998322254","https://openalex.org/W1999251984","https://openalex.org/W2005579982","https://openalex.org/W2020563252","https://openalex.org/W2022770236","https://openalex.org/W2023384909","https://openalex.org/W2024106968","https://openalex.org/W2027429767","https://openalex.org/W2037811259","https://openalex.org/W2039292392","https://openalex.org/W2039884289","https://openalex.org/W2047231993","https://openalex.org/W2071288349","https://openalex.org/W2078584174","https://openalex.org/W2084654786","https://openalex.org/W2408169250"],"related_works":["https://openalex.org/W1965326179","https://openalex.org/W2154584880","https://openalex.org/W2618014393","https://openalex.org/W1819654476","https://openalex.org/W2404302009","https://openalex.org/W2952062520","https://openalex.org/W2075716048","https://openalex.org/W2031744302","https://openalex.org/W2005579982","https://openalex.org/W2042084769"],"abstract_inverted_index":{"Sphingosine":[0],"kinases":[1],"(SPHKs)":[2],"catalyze":[3],"the":[4,7,43,49,90,118],"formation":[5],"of":[6,22,51,89,153],"bioactive":[8],"sphingolipid":[9],"metabolite":[10],"sphingosine":[11,85],"1-phosphate":[12],"(S1P),":[13],"which":[14],"plays":[15],"important":[16],"roles":[17],"in":[18,56,60,109,117],"a":[19,52,149,176],"wide":[20],"variety":[21],"intra-":[23],"and":[24,39,54,73,86,101,126,134,146,156,172,182],"extracellular":[25],"functions.":[26],"Conventionally,":[27],"SPHK":[28,58],"activity":[29],"has":[30],"been":[31],"determined":[32,104,116,129],"using":[33,92],"radioisotope":[34],"thin":[35],"layer":[36],"chromatography":[37],"(TLC)":[38],"autoradiography":[40],"to":[41,84,130,167],"detect":[42],"product":[44],"S1P.":[45],"Here":[46],"we":[47],"describe":[48],"development":[50],"simple":[53],"robust":[55],"vitro":[57],"assay":[59,76,107,162],"384-well":[61],"format":[62,163],"with":[63,105,112,148],"no":[64],"requirement":[65],"for":[66,124],"any":[67],"separation":[68],"steps":[69],"such":[70],"as":[71],"extraction":[72],"TLC.":[74],"The":[75,138,160],"is":[77,173],"based":[78],"on":[79],"(33)P-phosphate":[80],"transfer":[81],"from":[82],"[gamma-(33)P]ATP":[83],"subsequent":[87],"detection":[88],"[(33)P]S1P":[91],"AquaBind":[93],"plates":[94],"(Asahi":[95],"Techno":[96],"Glass,":[97],"Tokyo,":[98],"Japan).":[99],"Enzymatic":[100],"inhibition":[102],"characteristics":[103],"this":[106],"are":[108],"good":[110],"agreement":[111],"previously":[113],"reported":[114],"values":[115,123],"conventional":[119],"TLC":[120],"assay.":[121],"K(m)":[122],"D-erythro-sphingosine":[125],"ATP":[127],"were":[128],"be":[131,142],"17.5":[132],"microM":[133,155],"19.2":[135],"microM,":[136,158],"respectively.":[137,159],"kinase":[139],"reaction":[140],"could":[141],"inhibited":[143],"by":[144,175],"ADP":[145],"N,N-dimethylsphingosine":[147],"50%":[150],"inhibitory":[151],"concentration":[152],"410":[154],"450":[157],"established":[161],"was":[164],"easily":[165],"adapted":[166],"an":[168],"automated":[169],"screening":[170],"platform":[171],"characterized":[174],"high":[177],"signal-to-background":[178],"ratio,":[179],"small":[180],"variation,":[181],"excellent":[183],"Z":[184],"factors.":[185]},"counts_by_year":[{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
